<DOC>
	<DOCNO>NCT02364947</DOCNO>
	<brief_summary>The efficacy , safety , dose-response nalmefene hydrochloride 10 mg 20 mg patient alcohol dependence evaluate multicenter , randomize , double-blind , placebo-controlled , 3-parallel-group comparative trial . The superiority nalmefene hydrochloride 20 mg placebo verify term reduction alcohol consumption .</brief_summary>
	<brief_title>A Multicenter , Randomized , Double-blind , Placebo-controlled , 3-parallel-group Comparison Trial Investigate Effect Nalmefene Alcohol Consumption Reduction Patients With Alcohol Dependence ( Phase 3 Trial )</brief_title>
	<detailed_description />
	<mesh_term>Alcoholism</mesh_term>
	<mesh_term>Nalmefene</mesh_term>
	<mesh_term>Naltrexone</mesh_term>
	<criteria>Japanese male female age 20 sign informed consent form The patient alcohol dependence , diagnose accord Diagnostic Statistical Manual Mental Disorders , 4th Edition , Text Revision ( DSMIVTR ) confirm Miniinternational Neuropsychiatric Interview ( M. I. N . I . ) The patient current diagnosis history substance use disorder ( except alcohol , nicotine , caffeine ) , accord DSMIVTR confirm M. I. N. I . The patient report current use , test positive , drug abuse ( opiate , methadone , cocaine , amphetamine , barbiturate ) screen test</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>